Bio-Techne Corp
(BSP:T1CH34)
R$
12.24
+0.14 (+1.16%)
Market Cap: 57.21 Bil
Enterprise Value: 57.62 Bil
PE Ratio: 105.60
PB Ratio: 5.47
GF Score: 80/100 Bio-Techne Corp at Robert W Baird Global Healthcare Conference Transcript
Sep 12, 2023 / 08:55PM GMT
Release Date Price:
R$11.78
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Go ahead and get started. I'm Catherine Schulte, I cover life sciences and diagnostics here at Baird. Very excited to have Bio-Techne here with us today. From the company, we have CFO, Jim Hippel; and Head of IR, Dave Clair. So Dave, Jim, thanks so much for joining us.
James T. Hippel
Bio-Techne Corporation - Executive VP of Finance & CFO
Thanks for having us, and thanks for all of you. I can't believe it Clair. We got considered and we're bumping into a happy hour here. So I appreciate that.
Questions & Answers
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
I think we're going to dive right into Q&A. If anyone from the audience has a question, you can send it to [email protected], and I will pass it along to the team. So maybe first starting off, coming off your Investor Day last week, maybe just give us a
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot